Latest #massivebio Press Releases

Massive Bio plans acquisitions with Series B round

October 27, 2023

Massive Bio plans acquisitions with Series B round

Massive Bio, a New York-based company with an AI tool that matches cancer patients with clinical trials appropriate to their cancer diagnosis, is planning bolt-on acquisitions following a Series B...
Read More
Massive Bio Publishes the Second Issue of Massive Bio magazine

October 27, 2023

Massive Bio Publishes the Second Issue of Massive Bio magazine

November 2nd, 2022:  Massive Bio, a leader in AI-powered cancer clinical trial enrollment, has published the second issue of Massive Bio magazine. The publication, which had a successful debut i...
Read More
Massive Bio Launches ‘I Have Cancer’ Campaign

October 27, 2023

Massive Bio Launches ‘I Have Cancer’ Campaign

November 17th 2022: Massive Bio, which uses artificial intelligence to match cancer patients to clinical trials, launches "I Have Cancer," a social media campaign to raise cancer awareness.  In ...
Read More
Massive Bio Publishes the Second Issue of Massive Bio magazine

October 27, 2023

Massive Bio Publishes the Second Issue of Massive Bio magazine

November 2nd, 2022:  Massive Bio, a leader in AI-powered cancer clinical trial enrollment, has published the second issue of Massive Bio magazine. The publication, which had a successful debut i...
Read More